Form 4 Filing for Axsome Therapeutics, Inc.

This Form 4 filing details a transaction by Mark L. Jacobson, Chief Operating Officer of Axsome Therapeutics, Inc. On April 21, 2026, Jacobson acquired 8,669 Performance Stock Units (PSUs) with a transaction value of $0.00. These PSUs represent a contingent right to receive one share of the Issuer's common stock. The PSUs will vest upon the achievement of certain sales and commercial launch milestones, contingent upon Jacobson's continued service. Following this transaction, Jacobson holds 8,669 shares. The filing was signed by Mark Jacobson on April 23, 2026.